Medical Devices

A silent barrier in diabetes care, 'clinical inertia,' leaves patients at risk. New research shows how empowering pharmacists with targeted education can turn the tide.

Echo IQ partners with Mayo Clinic to test its AI for cardiac risk in cancer patients, a key move for validation in the burgeoning cardio-oncology sector.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

Kymera Therapeutics reports promising data for KT-621, a first-in-class oral drug that removes a key inflammatory protein, not just block it.

With a new CMO, Get A Drip is capitalizing on the longevity trend. But as it expands, it faces questions on scientific rigor and regulatory oversight.

Elixiron's enrupatinib shows promise in targeting neuroinflammation, with early data suggesting cognitive benefits and a new biomarker-guided path for therapy.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Beyond the accolades, the American National Standards Institute’s latest awards reveal the unsung heroes building our technological and economic future.

Abridge unveils a sweeping AI platform to combat clinician burnout and mend a fragmented system by linking care delivery, payment, and research.

In memory of her daughter Elora, a mother's foundation joins a global research network, turning personal tragedy into a collaborative fight against a rare cancer.

KPJ Healthcare launches a kidney transplant service, a strategic move addressing a national health crisis and reviving a fifty-year-old medical legacy.

While others chase flashy tech, LG's new Comfort Kit proves that small, thoughtful design changes can make the biggest difference in creating a home for all.

Despite a dip in NAV, Northern Venture Trust raises £30M and maintains dividends, bracing for the impact of a major VCT tax relief cut on UK startups.

With a massive Walmart and CVS launch, Mineral Ice Extreme isn't just selling a new gel; it's executing a classic CPG playbook to challenge giants.

With $75M and a playbook from Danaher's founder, Talon Precision aims to rebuild America's industrial base, one high-tech machine shop at a time.

Vivos Therapeutics' unusual rights offering isn't a simple plea for cash. It's a bold wager on its own turnaround and a case study in small-cap survival.

A novel case study reveals how targeted chemotherapy delivery is outsmarting stubborn tumors, highlighting a metabolic victory even when size remains unchanged.

A new FDA-approved therapy from Boehringer Ingelheim and a liquid biopsy from Guardant Health offer the first targeted initial treatment for HER2-mutant NSCLC.

For millions, the 'why' behind infertility remains a mystery. New genomic mapping tech is finally providing answers, changing the landscape of family planning.

Famed design firm Whipsaw is expanding beyond blueprints, hiring Roomba launch veteran Nancy Smith to build a new practice aimed at solving a key industry flaw.